Live Webinar

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Hosted by AJMC and Targeted Oncology

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
|Articles|February 17, 2018

Evidence-Based Oncology

  • February 2018
  • Volume 24
  • Issue 2

eAppendix

References for: Reimbursement Landscape for Molecular Testing in Non-Small Cell Lung Cancer

Download PDF: eAppendix

Articles in this issue

over 8 years ago

Medical World News: Clinical/Managed Care Updates

over 8 years ago

Medical World News: Clinical Updates

over 8 years ago

Medical World News: Regulatory Updates

over 8 years ago

Future Shock: Embracing Disruption in the Immunotherapy Revolution

over 8 years ago

With Approval of CAR T-Cell Therapy Comes the Next Challenge: Payer Coverage

over 8 years ago

Provocative Questions, Better Biomarkers, and the Prospect of Triple Therapy: A Conversation With NYU's Jeffrey S. Weber, MD, PhD

over 8 years ago

Recent Approval of Trastuzumab Biosimilar, Ogivri, Has Implications for Patients and Industry

over 8 years ago

The Clinical Trial and the Patient's Voice: "I'm Extremely Lucky to Be Alive"

over 8 years ago

Reimbursement Landscape for Molecular Testing in Non-Small Cell Lung Cancer

Related Content